Screener
Asset Entities ASST Medical device revenues — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| Investment advisory fees | $1,512 | $1,488 |
| Medical device revenues | 1,388 | — |
| Other revenue | 41 | 23 |
| Total revenues | 2,941 | 1,511 |
| Operating expenses: | ||
| Fund management and administration | 1,489 | 1,588 |
| Employee compensation and benefits | 16,314 | 2,005 |
| General and administrative expense | 6,428 | 1,452 |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device revenues — total revenues?
- Asset Entities (ASST) reported medical device revenues — total revenues of $1.39M in Q2 2026.
- What does medical device revenues — total revenues mean?
- This metric represents the proportion of total consolidated revenue derived specifically from medical device-related services or product offerings. It serves as a key indicator of the company's diversification into the healthcare technology sector and its ability to monetize specialized technical expertise outside of its core social media and digital marketing operations. Tracking this segment helps investors assess the growth trajectory and revenue contribution of the company's non-core business initiatives.
Ask your AI about Asset Entities's medical device revenues — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude